The Transcatheter Edge-to-Edge Repair (TEER) is a minimally invasive procedure to treat mitral regurgitation. It is for patients who are suffering from symptoms of valve-related congestive heart failure but aren’t responding to medication treatment and aren’t suitable candidates for surgery.
Valve insufficiency, or a leaky valve, causes a condition known as regurgitation. When this happens, blood that is supposed to be pumped out of the heart backflows, or leaks, back into the chamber. Patients can feel weak, light headed, short of breath, and experience chest pain. TEER closes the center of the mitral valve, allowing blood to flow to either side of the device and decreasing leakage.
CMC offers cutting-edge treatments for mitral valve repair using advanced, minimally invasive devices:
- MitraClip®: CMC is the first hospital in southern NH to offer this therapy, and one of the first in New England to implant the third generation MitraClip XTR. The procedure is performed through a catheter so it’s less invasive and has a much shorter recovery period than open heart surgery.
- Pascal: CMC is the first hospital in New England to offer this therapy after commercial approval.
Why choose CMC?
If you’re experiencing symptoms of heart valve disease, the Heart Valve Clinic’s multi-disciplinary team is dedicated to identifying the best therapies, emphasizing minimally invasive options, and helping you return to a fulfilling life.
Our Valve Clinic Coordinator, works alongside our team of board-certified cardiologists, cardiac surgeons and radiologists to offer treatment options for patients with heart valve disease.
The valve experts at the New England Heart & Vascular Institute will evaluate whether this procedure is right for you. This includes a review of your medical history and a variety of tests. Certain other factors, such as your age, frailty and the condition of your heart, factor into the decision.
The device is inserted through a catheter without the need to temporarily stop your heart and is implanted on your mitral valve. It only attaches to a small area of the mitral valve. The valve can still open and close on both sides of the device. This allows blood to flow on both sides of the device while reducing the flow of blood in the wrong direction.
In the days before your procedure, it is important to follow all of your provider’s instructions about medications, activity, and food and drink. Make sure you tell your care team about all the medications you are taking and if you have any known allergies.
After your procedure, you will be monitored in the hospital to assess your heart’s response. Most patients stay in the hospital for two to three days and typically do not require special assistance after discharge